Table 2.
DBP phenotype frequency in the studied groups.
| Groups | n | DBP phenotype | |||||
|---|---|---|---|---|---|---|---|
| Gc1s-1s n (%) |
Gc1s-1f n (%) |
Gc1s-2 n (%) |
Gc1f-1f n (%) |
Gc1f-2 n (%) |
Gc2-2 n (%) |
||
| Control | 306 | 117 (38.2) |
30 (9.8) |
119 (38.9) |
1 (0.3) |
17 (5.5) |
22∗∗
(7.2) |
| CAD | 154 | 78†
(50.6) |
14 (9.1) |
48 (31.2) |
1 (0.7) |
5 (3.2) |
8 (5.2) |
| Long-lived | 108 | 45 (41.7) |
8 (7.4) |
37 (34.3) |
0 | 3 (2.8) |
15 (13.9)∗ |
∗Gc2-2 phenotype frequency in the long-lived compared with the CAD group (p < 0.02).
∗∗Gc2-2 phenotype frequency in the control compared with the long-lived group (p < 0.04).
†Gc1s-1s phenotype frequency in the CAD compared with the control group (p < 0.02).